Page h1 hof h822
TEST BANK FOR Basic and Clinical Pharmacology
h h h h h h
h 15th Edition by Bertram G. Katzung
h h h h h h
Chapters 1 - 66 Complete
h h h h
, Page h2 hof h822
Table of Contents
h h
1. hIntroduction: hThe hNature hof hDrugs h& hDrug hDevelopment h& hRegulation
2. hDrug hReceptors h& hPharmacodynamics
3. hPharmacokinetics h& hPharmacodynamics: hRational hDosing h& hthe hTime hCourse hof hDrug hAction
4. hDrug hBiotransformation
5. hPharmacogenomics
6. hIntroduction hto hAutonomic hPharmacology
7. hCholinoceptor-Activating h& hCholinesterase-Inhibiting hDrugs
8. hCholinoceptor-Blocking hDrugs
9. hAdrenoceptor hAgonists h& hSympathomimetic hDrugs
10. hAdrenoceptor hAntagonist hDrugs
11. hAntihypertensive hAgents
12. hVasodilators h& hthe hTreatment hof hAngina hPectoris
13. hDrugs hUsed hin hHeart hFailure
14. hAgents hUsed hin hCardiac hArrhythmias
15. hDiuretic hAgents
16. hHistamine, hSerotonin, h& hthe hErgot hAlkaloids
17. hVasoactive hPeptides
18. hThe hEicosanoids: hProstaglandins, hThromboxanes, hLeukotrienes, h& hRelated hCompounds
19. hNitric hOxide
20. hDrugs hUsed hin hAsthma
21. hIntroduction hto hthe hPharmacology hof hCNS hDrugs
22. hSedative-Hypnotic hDrugs
23. hThe hAlcohols
24. hAntiseizure hDrugs
25. hGeneral hAnesthetics
26. hLocal hAnesthetics
27. hSkeletal hMuscle hRelaxants
28. hPharmacologic hManagement hof hParkinsonism h& hOther hMovement hDisorders
29. hAntipsychotic hAgents h& hLithium
30. hAntidepressant hAgents
31. hOpioid hAgonists h& hAntagonists
32. hDrugs hof hAbuse
33. hAgents hUsed hin hCytopenias; hHematopoietic hGrowth hFactors
34. hDrugs hUsed hin hDisorders hof hCoagulation
35. hAgents hUsed hin hDyslipidemia
36. hNonsteroidal hAnti-Inflammatory hDrugs, hDisease-Modifying hAntirheumatic hDrugs, hNonopioid hAnalgesics,
h& hDrugs hUsed hin hGout
37. hHypothalamic h& hPituitary hHormones
38. hThyroid h& hAntithyroid hDrugs
, Page h3 hof h822
39. hAdrenocorticosteroids h& hAdrenocortical hAntagonists
40. hThe hGonadal hHormones h& hInhibitors
41. hPancreatic hHormones h& hAntidiabetic hDrugs
42. hAgents hThat hAffect hBone hMineral hHomeostasis
43. hBeta-Lactam h& hOther hCell hWall- h& hMembrane-Active hAntibiotics
44. hTetracyclines, hMacrolides, hClindamycin, hChloramphenicol, hStreptogramins, h& hOxazolidinones
45. hAminoglycosides h& hSpectinomycin
46. hSulfonamides, hTrimethoprim, h& hQuinolones
47. hAntimycobacterial hDrugs
48. hAntifungal hAgents
49. hAntiviral hAgents
50. hMiscellaneous hAntimicrobial hAgents; hDisinfectants, hAntiseptics, h& hSterilants
51. hClinical hUse hof hAntimicrobial hAgents
52. hAntiprotozoal hDrugs
53. hClinical hPharmacology hof hthe hAntihelminthic hDrugs
54. hCancer hChemotherapy
55. hImmunopharmacology
56. hIntroduction hto hToxicology: hOccupational h& hEnvironmental
57. hHeavy hMetal hIntoxication h& hChelators
58. hManagement hof hthe hPoisoned hPatient
59. hSpecial hAspects hof hPerinatal h& hPediatric hPharmacology
60. hSpecial hAspects hof hGeriatric hPharmacology
61. hDermatologic hPharmacology
62. hDrugs hUsed hin hthe hTreatment hof hGastrointestinal hDiseases
63. hTherapeutic h& hToxic hPotential hof hOver-the-Counter hAgents
64. hDietary hSupplements h& hHerbal hMedications
65. hRational hPrescribing h& hPrescription hWriting
66. hImportant hDrug hInteractions h& hTheir hMechanisms h
, Page h4 hof h822
Chapter 1. Introduction: The Nature of Drugs & Drug Development & Regulation
h h h h h h h h h h h
1. A hnurse hworking hin hradiology hadministers hiodine hto ha hpatient hwho his hhaving
ha hcomputed htomography h(CT) hscan. hThe hnurse hworking hon hthe honcology
hunit hadministers hchemotherapy hto hpatients hwho hhave hcancer. hAt hthe hPublic
hHealth hDepartment, ha hnurse hadministers ha hmeasles-mumps-rubella h(MMR)
hvaccine htoh
a h14-month-old hchild has ha hroutine himmunization. hWhich hbranch
hof hpharmacology hbest hdescribes hthe hactions hof hall hthree h nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology his hthe hstudy hof hthe hbiologic heffects hof hchemicals. hNurses hare
hinvolved hwith hclinical hpharmacology hor hpharmacotherapeutics, hwhich his ha
hbranch hof hpharmacology hthat hdeals hwith hthe huses hof hdrugs hto htreat, hprevent,
hand hdiagnose hdisease. hThe hradiology hnurse his hadministering ha hdrug hto hhelp
hdiagnose ha hdisease. hThe honcology hnurse his hadministering ha hdrug hto hhelp
htreat hah
disease. hPharmacoeconomics hincludes hany hcosts hinvolved hin hdrug
h therapy.
Pharmacodynamics hinvolves hhow ha hdrug haffects hthe hbody
handhpharmacokinetics his hhow hthe hbody hacts hon hthe hbody.
2. A hphysician hhas hordered hintramuscular h(IM) hinjections hof hmorphine, ha
hnarcotic, hevery h4 hhours has hneeded hfor hpain hin ha hmotor hvehicle haccident
hvictim.h
The hnurse his haware hthis hdrug hhas ha hhigh habuse hpotential. hUnder
hwhat hcategoryhwould hmorphine hbe h classified?
A) Schedule hI
B) Schedule hII
TEST BANK FOR Basic and Clinical Pharmacology
h h h h h h
h 15th Edition by Bertram G. Katzung
h h h h h h
Chapters 1 - 66 Complete
h h h h
, Page h2 hof h822
Table of Contents
h h
1. hIntroduction: hThe hNature hof hDrugs h& hDrug hDevelopment h& hRegulation
2. hDrug hReceptors h& hPharmacodynamics
3. hPharmacokinetics h& hPharmacodynamics: hRational hDosing h& hthe hTime hCourse hof hDrug hAction
4. hDrug hBiotransformation
5. hPharmacogenomics
6. hIntroduction hto hAutonomic hPharmacology
7. hCholinoceptor-Activating h& hCholinesterase-Inhibiting hDrugs
8. hCholinoceptor-Blocking hDrugs
9. hAdrenoceptor hAgonists h& hSympathomimetic hDrugs
10. hAdrenoceptor hAntagonist hDrugs
11. hAntihypertensive hAgents
12. hVasodilators h& hthe hTreatment hof hAngina hPectoris
13. hDrugs hUsed hin hHeart hFailure
14. hAgents hUsed hin hCardiac hArrhythmias
15. hDiuretic hAgents
16. hHistamine, hSerotonin, h& hthe hErgot hAlkaloids
17. hVasoactive hPeptides
18. hThe hEicosanoids: hProstaglandins, hThromboxanes, hLeukotrienes, h& hRelated hCompounds
19. hNitric hOxide
20. hDrugs hUsed hin hAsthma
21. hIntroduction hto hthe hPharmacology hof hCNS hDrugs
22. hSedative-Hypnotic hDrugs
23. hThe hAlcohols
24. hAntiseizure hDrugs
25. hGeneral hAnesthetics
26. hLocal hAnesthetics
27. hSkeletal hMuscle hRelaxants
28. hPharmacologic hManagement hof hParkinsonism h& hOther hMovement hDisorders
29. hAntipsychotic hAgents h& hLithium
30. hAntidepressant hAgents
31. hOpioid hAgonists h& hAntagonists
32. hDrugs hof hAbuse
33. hAgents hUsed hin hCytopenias; hHematopoietic hGrowth hFactors
34. hDrugs hUsed hin hDisorders hof hCoagulation
35. hAgents hUsed hin hDyslipidemia
36. hNonsteroidal hAnti-Inflammatory hDrugs, hDisease-Modifying hAntirheumatic hDrugs, hNonopioid hAnalgesics,
h& hDrugs hUsed hin hGout
37. hHypothalamic h& hPituitary hHormones
38. hThyroid h& hAntithyroid hDrugs
, Page h3 hof h822
39. hAdrenocorticosteroids h& hAdrenocortical hAntagonists
40. hThe hGonadal hHormones h& hInhibitors
41. hPancreatic hHormones h& hAntidiabetic hDrugs
42. hAgents hThat hAffect hBone hMineral hHomeostasis
43. hBeta-Lactam h& hOther hCell hWall- h& hMembrane-Active hAntibiotics
44. hTetracyclines, hMacrolides, hClindamycin, hChloramphenicol, hStreptogramins, h& hOxazolidinones
45. hAminoglycosides h& hSpectinomycin
46. hSulfonamides, hTrimethoprim, h& hQuinolones
47. hAntimycobacterial hDrugs
48. hAntifungal hAgents
49. hAntiviral hAgents
50. hMiscellaneous hAntimicrobial hAgents; hDisinfectants, hAntiseptics, h& hSterilants
51. hClinical hUse hof hAntimicrobial hAgents
52. hAntiprotozoal hDrugs
53. hClinical hPharmacology hof hthe hAntihelminthic hDrugs
54. hCancer hChemotherapy
55. hImmunopharmacology
56. hIntroduction hto hToxicology: hOccupational h& hEnvironmental
57. hHeavy hMetal hIntoxication h& hChelators
58. hManagement hof hthe hPoisoned hPatient
59. hSpecial hAspects hof hPerinatal h& hPediatric hPharmacology
60. hSpecial hAspects hof hGeriatric hPharmacology
61. hDermatologic hPharmacology
62. hDrugs hUsed hin hthe hTreatment hof hGastrointestinal hDiseases
63. hTherapeutic h& hToxic hPotential hof hOver-the-Counter hAgents
64. hDietary hSupplements h& hHerbal hMedications
65. hRational hPrescribing h& hPrescription hWriting
66. hImportant hDrug hInteractions h& hTheir hMechanisms h
, Page h4 hof h822
Chapter 1. Introduction: The Nature of Drugs & Drug Development & Regulation
h h h h h h h h h h h
1. A hnurse hworking hin hradiology hadministers hiodine hto ha hpatient hwho his hhaving
ha hcomputed htomography h(CT) hscan. hThe hnurse hworking hon hthe honcology
hunit hadministers hchemotherapy hto hpatients hwho hhave hcancer. hAt hthe hPublic
hHealth hDepartment, ha hnurse hadministers ha hmeasles-mumps-rubella h(MMR)
hvaccine htoh
a h14-month-old hchild has ha hroutine himmunization. hWhich hbranch
hof hpharmacology hbest hdescribes hthe hactions hof hall hthree h nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology his hthe hstudy hof hthe hbiologic heffects hof hchemicals. hNurses hare
hinvolved hwith hclinical hpharmacology hor hpharmacotherapeutics, hwhich his ha
hbranch hof hpharmacology hthat hdeals hwith hthe huses hof hdrugs hto htreat, hprevent,
hand hdiagnose hdisease. hThe hradiology hnurse his hadministering ha hdrug hto hhelp
hdiagnose ha hdisease. hThe honcology hnurse his hadministering ha hdrug hto hhelp
htreat hah
disease. hPharmacoeconomics hincludes hany hcosts hinvolved hin hdrug
h therapy.
Pharmacodynamics hinvolves hhow ha hdrug haffects hthe hbody
handhpharmacokinetics his hhow hthe hbody hacts hon hthe hbody.
2. A hphysician hhas hordered hintramuscular h(IM) hinjections hof hmorphine, ha
hnarcotic, hevery h4 hhours has hneeded hfor hpain hin ha hmotor hvehicle haccident
hvictim.h
The hnurse his haware hthis hdrug hhas ha hhigh habuse hpotential. hUnder
hwhat hcategoryhwould hmorphine hbe h classified?
A) Schedule hI
B) Schedule hII
